SPONSOR
Xuzhou Medical University
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Multiple MyelomaAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Xuzhou Medical University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xuzhou Medical University
How many clinical trials has Xuzhou Medical University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Xuzhou Medical University, of which 2 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xuzhou Medical University research focus on?
Xuzhou Medical University clinical trials span Multiple Myeloma, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xuzhou Medical University clinical trial?
To participate in a Xuzhou Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xuzhou Medical University trials with current recruitment status updated daily.
Clinical Trials by Xuzhou Medical University
NCT06759181 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
Multiple Myeloma
NCT06125652 Phase 1, Phase 2
Recruiting
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
Acute Myeloid Leukemia Refractory
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology